참고문헌
- Arnon, S. A., Schecter, R., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine. A. D., Hauer, J., Layton, M., Lillibridge, S., Osterholm, M. T., O'Toole, T., Parker, G., Perl, T. M., Russell, P. K., Swerdlow, D. L. and Tonat, K. (2001) Botulinum toxin as a biological weapon: medical and public health management. J. Am. Med. Assoc. 285, 1059-1070. https://doi.org/10.1001/jama.285.8.1059
- Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254. https://doi.org/10.1016/0003-2697(76)90527-3
- Carruthers, J. and Carruthers, A. (1998) The adjunctive usage of botulinum toxin. Dermatol. Surg. 24, 1244-1247. https://doi.org/10.1016/S1076-0512(98)00188-5
- Center for Disease Control (1998) Botulism in the United States, 1899-1998. Handbook for Epidemiologists, Clinnicans, and Laboratory Workers. Atlanta, Georgia US Department of Health and Human Services, Public Health Service.
- Choi, H. S., An, J. J., Kim, S. Y., Lee, S. H., Kim, D. W., Yoo, K. Y., Won, M. H., Kang, T. C., Kwon, H. J., Kang, J. H., Cho, S. W., Kwon, O. S., Park, J., Eum, W. S. and Choi, S. Y. (2006) PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron in Parkinson's Disease mouse model. Free Radic. Biol. Med. In press.
- Choi, S. H., Kim, D. W., Kim, S. Y., An, J. J., Lee, S. H., Sohn, E. J., Hwang, S. I., Won, M. H., Kang, T. C., Kwon, H. J., Kang, J. H., Cho, S. W., Park, J., Eum, W. S. and Choi, S. Y. (2005) Transduced human copper chaperone for Cu, Zn-SOD (PEP-1-CCS) protects against neuronal cell death. Mol. Cells 20, 401-408.
- Christopher, G. W., Cieslak, T. J., Pavlin, J. A. and Eitzen Jr, E. M. (1997) Biological warfare. A historical perspective. J. Am. Med. Assoc. 278, 412-417. https://doi.org/10.1001/jama.278.5.412
- Cordivari, C., Misra, P. V., Catania, S. and Lees, A. J. (2004) New therapeutic indications for botulinum toxins. Mov. Disord. 19, 157-161. https://doi.org/10.1002/mds.20071
- De Maio, M. (2003) Botulinum toxin in associated with other rejuvenation methods. J. Cosmetic Laser Ther. 5, 210-212. https://doi.org/10.1080/14764170310021896
- Eum W. S., Choung, I. S., Li, M. Z., Kang, J. H., Kim, D. W., Park, J., Kwon, H. Y. and Choi, S. Y. (2004a) HIV-1 Tat mediated protein transduction of Cu,Zn-superoxide dismutase into pancreatic b cells in vitro and in vivo. Free Radic. Biol. Med. 37, 339-349. https://doi.org/10.1016/j.freeradbiomed.2004.04.036
- Eum, W. S., Kim, D. W., Hwang, I. K., Yoo, K. Y., Kang, T. C., Jang, S. H., Choi, H. S., Choi, S. H., Kim, Y. H., Kim, S. Y., Kwon, H. Y., Kang, J. H., Kwon, O. S., Cho, S. W., Lee, K. S., Park, J., Won, M. H. and Choi, S. Y. (2004b) In vivo protein transduction: Biologically active intact PEP-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radic. Biol. Med. 37, 1656-1669. https://doi.org/10.1016/j.freeradbiomed.2004.07.028
- Fawell, S., Seery, J. and Daikh, Y. (1991) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91, 664-668.
- Ha, K. T., Lee, Y. C., Cho, S. H., Kim, J. K. and Kim, C. H. (2004) Molecular characterization of membrane type and ganglioside-specific sialidase (Neu3) expressed in E. coli. Mol. Cells 17, 267-273.
- Hwang, J. H., Yuk, S. H., Lee, J. H., Lyoo, W. S., Ghil, S. H., Lee, S. S., Khang, I. G., Paik, S. Y. and Lee, J. Y. (2004) Differentiation of stem cells isolated from rat smooth muscle. Mol. Cells 17, 57-61.
- Kim, C. H. (2003) A Salmonella typhimurium rfaE mutants recovers invasiveness for human epithelial cells when complemented by wild type rfaE (confering biosynthesis of ADP-L-glycero-Dmanno-heptose-containing lipopolysaccharide). Mol. Cells 15, 226-232.
- Kim, D. W., Eum, W. S., Jang, S. H., Kim, S. Y., Choi, H. S., Choi, S. H., An, J. J., Lee, S. H., Lee, K. S., Han, K., Kang, T. C., Won, M. H., Kang, J. H., Kwon, O. S., Cho, S. W., Kim, T. Y., Park, J. and Choi, S. Y. (2005) Transduced Tat-SOD fusion protein protects against ischemic brain injury. Mol. Cells 19, 88-96.
- Kim, S. Y., An, J. J., Kim, D. W., Choi, S. H., Lee, S. H., Hwang, S. I., Kwon, O. S., Kang, T. C., Won, M. H., Cho, S. W., Park, J., Eum, W. S., Lee, K. S. and Choi, S. Y. (2006) Tat-mediated Protein Transduction of Human Brain Pyridoxine-5-P Oxidase into PC12 Cells. J. Biochem. Mol. Biol. 39, 76-83. https://doi.org/10.5483/BMBRep.2006.39.1.076
- Klein, A. W. (2004) The therapeutic potential of botulinum toxin. Dermatol. Surg. 30, 452-455. https://doi.org/10.1111/j.1524-4725.2004.30118.x
- Lacy, B. D. and Stevens, R. C. (1999) Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 291, 1091-1104. https://doi.org/10.1006/jmbi.1999.2945
- Mauskop, A. (2002) The use of botulinum toxin in the treatment of headaches. Curr. Pain Headache Rep. 6, 320-323. https://doi.org/10.1007/s11916-002-0054-1
- Mauskop, A. and Basdeo, R. (2000) Botulinum toxin A is an effective prophylactic therapy for migraines. Cephalagia 20, 422.
- Montecucco, C. and Schiavo, G. (1994) Mechanism of action of tetanus and botulinum neurotoxins. Mol. Microbiol. 13, 1-8. https://doi.org/10.1111/j.1365-2958.1994.tb00396.x
- Morris, M. C., Depollier, J., Mery, J., Heitz, F. and Divita, G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19, 1173-1176. https://doi.org/10.1038/nbt1201-1173
- Oguma, K., Fujinaga, Y. and Inoue, K. (1995) Structure and function of Clostridium botulinum toxins. Microbiol. Immunol. 39, 161-168. https://doi.org/10.1111/j.1348-0421.1995.tb02184.x
- Prochiantz, A. (2000) Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell Biol. 12, 400-406. https://doi.org/10.1016/S0955-0674(00)00108-3
- Sarrabayrouse, M. A. M. (2002) Indications and limitations for the use of botulinum toxin for the treatment of facial wrinkles. Aesth. Plast. Surg. 26, 233-238. https://doi.org/10.1007/s00266-002-2030-x
- Schiavo, G., Matteoli, M. and Montecucco, C. (2000) Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80, 717-766. https://doi.org/10.1152/physrev.2000.80.2.717
- Schmidt, J. J. and Bostian, K. A. (1995) Proteolysis of synthetic peptides by type A botulinum neurotoxin. J. Protein Chem. 14, 703-708. https://doi.org/10.1007/BF01886909
- Sugiyama, H. (1980) Clostidium botulinum neurotoxin. Microbiol. Rev. 44, 419-448.
- Verheyden, J. and Blitzer, A. (2002) Other noncosmetic uses of BOTOX. Dis. Mon. 48, 357-366. https://doi.org/10.1053/mda.2001.25136
- Vives, E., Brodin, P. and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017. https://doi.org/10.1074/jbc.272.25.16010
- Wadia, J. S. and Dowdy, S. F. (2002) Protein transduction technology. Curr. Opin. Biotechnol. 13, 52-56. https://doi.org/10.1016/S0958-1669(02)00284-7
- Wheeler, A. H. (1997) Therapeutic uses of botulinum toxin. Am. Fam. Physican 55, 541-545, 548.
피인용 문헌
- Intracellular delivery of proteins into mouse Müller glia cells in vitro and in vivo using Pep-1 transfection reagent vol.177, pp.2, 2009, https://doi.org/10.1016/j.jneumeth.2008.10.039
- Cell-penetrating Peptides as a Novel Transdermal Drug Delivery System vol.80, pp.5, 2012, https://doi.org/10.1111/cbdd.12008
- Expression and purification of recombinant TAT-BoNT/A(1–448) under denaturing and native conditions vol.7, pp.6, 2016, https://doi.org/10.1080/21655979.2016.1201252
- Physicochemical and Biological Characterization of Pep-1/Elastin Complexes vol.82, pp.2, 2013, https://doi.org/10.1111/cbdd.12150
- Towards New Uses of Botulinum Toxin as a Novel Therapeutic Tool vol.3, pp.12, 2011, https://doi.org/10.3390/toxins3010063
- TAT-BoNT/A(1–448), a novel fusion protein as a therapeutic agent: analysis of transcutaneous delivery and enzyme activity vol.100, pp.6, 2016, https://doi.org/10.1007/s00253-015-7240-7